Adv Exp Med Biol. 2011;780:69-83. doi: 10.1007/978-1-4419-5632-3_7.
Generating a large population of memory CD8 T cells is an appealing goal for vaccine design against a variety of human diseases. Indeed, experimental models have demonstrated that the overall number of memory CD8 T cells present at the time of infection correlates strongly with the ability to confer host protection against a range of different pathogens. Currently, the most conceivable approach to rapidly generate a large population of memory CD8 T cells is through the use of prime-boost vaccination. In addition, recent experimental findings have uncovered important principles that govern both the rate and magnitude of memory CD8 T cell formation. Thus, this has resulted in novel prime-boost vaccination strategies that could potentially be used in humans to generate protective populations of memory CD8 T cells.
产生大量记忆 CD8 T 细胞是针对各种人类疾病设计疫苗的一个吸引人的目标。事实上,实验模型已经证明,感染时存在的记忆 CD8 T 细胞的总数与赋予宿主针对一系列不同病原体的保护能力密切相关。目前,最可行的方法是通过使用初始-加强免疫接种来快速产生大量的记忆 CD8 T 细胞。此外,最近的实验结果揭示了控制记忆 CD8 T 细胞形成的速度和幅度的重要原则。因此,这导致了新的初始-加强免疫接种策略,这些策略有可能在人类中用于产生保护性的记忆 CD8 T 细胞群体。